FXR signaling also modulates junctional proteins and inflammation, but reports differ across models—some studies find FXR activation supports barrier function, whereas others have reported that FXR deletion can attenuate barrier dysfunction in acute colitis settings.39 This evidence concerns the gene NR1H4 and colitis.